FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Conrad Raab

Research Profile

Chemicals & Drugs

Living Beings

Procedures

Anatomy

Physiology

Binding, Competitive

Co-author Network

Publications

TOP 3
Linus S Lin; Thomas J Lanza; James P Jewell; Ping Liu; Carrie Jones; Gerard R Kieczykowski; Kelly Treonze; Qian Si; Salony Manior; Gloria C Koo; Xinchun Tong; Junying Wang; Anne Schuelke; James V Pivnichny; Regina Wang; Conrad E Raab; Stella Vincent; Philip Davies; Malcolm MacCoss; Richard A Mumford; William K Hagmann
Discovery of N-{N-[(3-cyanophenyl)sulfonyl]-4(R)-cyclobutylamino-(L)-prolyl}-4-[(3',5'-dichloroisonicotinoyl) amino]-(L)-phenylalanine (MK-0668), an extremely potent and orally active antagonist of very late antigen-4.
Cuyue Tang; Brian A Carr; Frédéric Poignant; Bennett Ma; Stacey L Polsky-Fisher; Yuhsin Kuo; Kristie Strong-Basalyga; Alisha Norcross; Karen Richards; Roy Eisenhandler; Edward J Carlini; Christina N Di Marco; Scott D Kuduk; Nathan X Yu; Conrad E Raab; Thomas H Rushmore; Clay B Frederick; Mark G Bock; Thomayant Prueksaritanont
CYP2C75-involved autoinduction of metabolism in rhesus monkeys of methyl 3-chloro-3'-fluoro-4'-{(1R)-1-[({1-[(trifluoroacetyl)amino]cyclopropyl}carbonyl)amino]ethyl}-1,1'-biphenyl-2-carboxylate (MK-0686), a bradykinin B1 receptor antagonist.
Conrad E Raab; John W Butcher; Thomas M Connolly; Jerzy Karczewski; Nathan X Yu; Steven J Staskiewicz; Nigel J Liverton; Dennis C Dean; David G Melillo
Synthesis of the first sulfur-35-labeled hERG radioligand.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Conrad Raab (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Linus S Lin; Thomas J Lanza; James P Jewell; Ping Liu; Carrie Jones; Gerard R Kieczykowski; Kelly Treonze; Qian Si; Salony Manior; Gloria C Koo; Xinchun Tong; Junying Wang; Anne Schuelke; James V Pivnichny; Regina Wang; Conrad E Raab; Stella Vincent; Philip Davies; Malcolm MacCoss; Richard A Mumford; William K Hagmann
Discovery of N-{N-[(3-cyanophenyl)sulfonyl]-4(R)-cyclobutylamino-(L)-prolyl}-4-[(3',5'-dichloroisonicotinoyl) amino]-(L)-phenylalanine (MK-0668), an extremely potent and orally active antagonist of very late antigen-4.
Journal of medicinal chemistry 2009;52(11):3449-52.
2008: Cuyue Tang; Brian A Carr; Frédéric Poignant; Bennett Ma; Stacey L Polsky-Fisher; Yuhsin Kuo; Kristie Strong-Basalyga; Alisha Norcross; Karen Richards; Roy Eisenhandler; Edward J Carlini; Christina N Di Marco; Scott D Kuduk; Nathan X Yu; Conrad E Raab; Thomas H Rushmore; Clay B Frederick; Mark G Bock; Thomayant Prueksaritanont
CYP2C75-involved autoinduction of metabolism in rhesus monkeys of methyl 3-chloro-3'-fluoro-4'-{(1R)-1-[({1-[(trifluoroacetyl)amino]cyclopropyl}carbonyl)amino]ethyl}-1,1'-biphenyl-2-carboxylate (MK-0686), a bradykinin B1 receptor antagonist.
The Journal of pharmacology and experimental therapeutics 2008;325(3):935-46.
2006: Conrad E Raab; John W Butcher; Thomas M Connolly; Jerzy Karczewski; Nathan X Yu; Steven J Staskiewicz; Nigel J Liverton; Dennis C Dean; David G Melillo
Synthesis of the first sulfur-35-labeled hERG radioligand.
Bioorganic & medicinal chemistry letters 2006;16(6):1692-5.
2005: Christopher R Gibson; Charles Lin; Rominder Singh; Cheri M Brown; Karen Richards; Janice Brunner; Kimberly Michel; Jennifer K Adelsberger; Edward J Carlini; Catherine Boothe-Genthe; Conrad E Raab; Minh Luu; Aimee Michael; Mona Parikh; Patrice A Ciecko; Raju Subramanian; Paul Krolikowski; A David Rodrigues; Thomas A Baillie; Thomas H Rushmore
Induction of CYP1A in the beagle dog by an inhibitor of kinase insert domain-containing receptor: differential effects in vitro and in vivo on mRNA and functional activity.
Drug metabolism and disposition: the biological fate of chemicals 2005;33(7):1044-51.
2004: Dai-Shi Su; M Kristine Markowitz; Kathy L Murphy; Bang-Lin Wan; Matthew M Zrada; Charles M Harrell; Stacy S O'Malley; J Fred Hess; Richard W Ransom; Raymond S L Chang; Michael A Wallace; Conrad E Raab; Dennis C Dean; Douglas J Pettibone; Roger M Freidinger; Mark G Bock
Development of an efficient and selective radioligand for bradykinin B1 receptor occupancy studies.
Bioorganic & medicinal chemistry letters 2004;14(24):6045-8.
2004: Richard W Ransom; Charles M Harrell; Duane R Reiss; Kathy L Murphy; Raymond S L Chang; J Fred Hess; Patricia J Miller; Stacy S O'Malley; Patricia J Hey; Priya Kunapuli; Dai-Shi Su; M Kristine Markowitz; Michael A Wallace; Conrad E Raab; Allen Jones; Dennis C Dean; Douglas J Pettibone; Roger M Freidinger; Mark G Bock
Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist.
European journal of pharmacology 2004;499(1-2):77-84.
2004: William H Schaefer; Jeffery W Lawrence; Amy F Loughlin; Dana A Stoffregen; Lori A Mixson; Dennis C Dean; Conrad E Raab; Nathan X Yu; George R Lankas; Clay B Frederick
Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats.
Toxicology and applied pharmacology 2004;194(1):10-23.
2003: Ping Lu; Michael L Schrag; Donald E Slaughter; Conrad E Raab; Magang Shou; A David Rodrigues
Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor.
Drug metabolism and disposition: the biological fate of chemicals 2003;31(11):1352-60.
2003: Maria G Beconi; Ann Mao; David Q Liu; Christopher J Kochansky; Tony Pereira; Conrad E Raab; Paul Pearson; Shuet-Hing Lee Chiu
Metabolism and pharmacokinetics of a dipeptidyl peptidase IV inhibitor in rats, dogs, and monkeys with selective carbamoyl glucuronidation of the primary amine in dogs.
Drug metabolism and disposition: the biological fate of chemicals 2003;31(10):1269-77.
2003: Linda A Egger; Jin Cao; Christine McCallum; Usha Kidambi; Gail Van Riper; Ermengilda McCauley; Richard A Mumford; Thomas J Lanza; Linus S Lin; Stephen E de Laszlo; David N Young; Ginger Yang; Dennis C Dean; Conrad E Raab; Michael A Wallace; Allen Jones; William K Hagmann; John A Schmidt; R Blake Pepinsky; Daniel M Scott; Wen-Cherng Lee; Mark Cornebise; Patricia A Detmers
A small molecule alpha4beta1/alpha4beta7 antagonist differentiates between the low-affinity states of alpha4beta1 and alpha4beta7: characterization of divalent cation dependence.
The Journal of pharmacology and experimental therapeutics 2003;306(3):903-13.
2002: Cornelis E C A Hop; Yanfeng Wang; Sanjeev Kumar; Maria Victoria Silva Elipe; Conrad E Raab; Dennis C Dean; Grace K Poon; Carol Ann Keohane; John Strauss; Shuet-Hing Lee Chiu; Neil Curtis; Jason Elliott; Ute Gerhard; Karen Locker; Denise Morrison; Russell Mortishire-Smith; Steven Thomas; Alan P Watt; David C Evans
Identification of metabolites of a substance P (neurokinin 1 receptor) antagonist in rat hepatocytes and rat plasma.
Drug metabolism and disposition: the biological fate of chemicals 2002;30(8):937-43.
2002: R Blake Pepinsky; Richard A Mumford; Ling Ling Chen; Diane R Leone; Suzanne E Amo; Gail Van Riper; Adrian Whitty; Brian M Dolinski; Roy R Lobb; Dennis C Dean; Linda L Chang; Conrad E Raab; Qian Si; William K Hagmann; Russell Lingham
Comparative assessment of the ligand and metal ion binding properties of integrins alpha9beta1 and alpha4beta1.
Biochemistry 2002;41(22):7125-41.
2002: Alison L Fisher; Elizabeth DePuy; Andrew Jayaraj; Conrad E Raab; Matt Braun; Michelle Ellis-Hutchings; Jin Zhang; John D Rogers; Donald G Musson
LC/MS/MS plasma assay for the peptidomimetic VLA4 antagonist I and its major active metabolite II: for treatment of asthma by inhalation.
Journal of pharmaceutical and biomedical analysis 2002;27(1-2):57-71.
2001: Tamara A Kale; Conrad E Raab; N Yu; Dennis C Dean; Mark D Distefano
A photoactivatable prenylated cysteine designed to study isoprenoid recognition.
Journal of the American Chemical Society 2001;123(19):4373-81.
2001: Philip R Tiller; Conrad E Raab; Cornelis E C A Hop
An unusual fragmentation mechanism involving the transfer of a methyl group.
Journal of mass spectrometry : JMS 2001;36(3):344-5.
1999: Wei Tang; Ralph A Stearns; S M Bandiera; Y Zhang; Conrad E Raab; Matthew P Braun; Dennis C Dean; Jianmei Pang; Kwan H Leung; George A Doss; John R Strauss; Gloria Y Kwei; Thomas H Rushmore; Shuet-Hing Lee Chiu; Thomas A Baillie
Studies on cytochrome P-450-mediated bioactivation of diclofenac in rats and in human hepatocytes: identification of glutathione conjugated metabolites.
Drug metabolism and disposition: the biological fate of chemicals 1999;27(3):365-72.